Paul Kennedy1,2, Sara Lewis1,2, Octavia Bane1,2, Stefanie Hectors1,2, Maxwell Segall1, Edward Kim2, and Bachir Taouli1,2
1Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, United States, 2Department of Radiology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY, United States
Synopsis
The goal of the
current study was to assess the changes in hepatocellular carcinoma (HCC)
stiffness using 2D MR elastography (MRE) at baseline and 6 weeks after 90Yttrium radioembolization (RE).
Preliminary results are presented in 10 patients and show that HCC stiffness and
liver stiffness adjacent to the treated lesion are both significantly increased
6w after therapy. Percentage change in tumor stiffness is significantly
correlated with degree of tumor necrosis at 6w.
Introduction
90Yttrium radioembolization (RE) is a locoregional therapy that may be used
as a bridge to liver transplantation in patients with HCC or in advanced HCC. In
this study we assess prospectively the effect of RE on the mechanical
properties of the index treated lesions and the surrounding liver parenchyma by
measuring tissue stiffness using MRE.Methods
In
this preliminary IRB-approved single center study, MRE was performed on 13 prospectively
enrolled cirrhotic patients (M/F 9/4, mean age 69y) before and approximately 6w
after RE (12 segmental, 1 lobar) for HCC (mean interval between RE and post
treatment MRI: 42.4±2.6
d). MRE was performed at 1.5T (Aera, Siemens) using a single breath hold axial 2D
SE-EPI sequence. Data was reconstructed inline by a commercially available
inversion algorithm1. The change in stiffness,
measured as the magnitude of the complex shear modulus, |G*|, was assessed in
the liver parenchyma away from the treated lobe/segment, liver parenchyma in
the treated lobe/segment and the index lesion. A radiologist assessed treatment
response at 6w by calculating degree of tumor necrosis on subtracted post-contrast
T1 weighted VIBE images (after injection of gadoxetic acid,
Eovist/Primovist, Bayer). Stiffness changes following RE were tested for
significance using Wilcoxon signed-rank tests. Mann-Whitney U tests were used
to determine the significance of within-subject differences in parenchyma and
lesion stiffness. Spearman correlations were calculated between stiffness
measurements and degree of tumor necrosis at 6w. Results
MRE was unsuccessful in 3 patients. Thus, 10 HCCs (mean size 3.4±1.9 cm, range 1.5cm-8cm) were analyzed
in 10 patients. Hemorrhage was present in 9/10 treated lesions at 6w. An
example pre and post RE elastogram is shown in Figure 1. Pre and post stiffness values for the measured tissues are
displayed in Table 1. At baseline
there was no significant difference between liver parenchyma stiffness and
tumor stiffness (p=0.44). However,
following RE, tumor stiffness was higher than liver stiffness away from the
treated area, with a trend towards significance (4.44±0.91 vs 6.91±4.22 kPa, p=0.053). Tumor stiffness was
significantly increased after RE (4.53±2.44 vs 6.91±4.22 kPa, p=0.005; Figure 2), with mean percentage increase of 55.6%±44.6%. Tumor
stiffness increase was <5% in 2/10 tumors and >15% in the remaining 8
tumors (range 17%-155%). Percentage change in tumor stiffness was significantly
associated with degree of tumor necrosis at 6w post RE (r=0.665, p=0.036). Tumor
stiffness at 6w was negatively correlated with necrosis but the relationship
was not significant (r=-0.540, p=0.11). Liver stiffness adjacent to the
treated lesion was also significantly increased following therapy (4.06±1.38 vs
5.41±1.87 kPa, p=0.037; Figure 3). No difference was observed
in liver stiffness away from the treated area after RE (4.88±1.23 vs 4.44±0.91 kPa, p=0.21). Discussion
These
preliminary results suggest that HCC tumor
stiffness and stiffness of surrounding liver increase at 6w after RE, and the
percentage change in stiffness is significantly correlated with degree of tumor
necrosis at 6w. A previous study reported a significant negative correlation
between tumor stiffness post treatment and necrosis2. In our study we also
observed a negative correlation between tumor stiffness post treatment and
degree of necrosis however it was not significant, potentially due to the small
sample size. Also, the median interval between treatment and imaging was twice
as long as that in our study (85 vs 42 days). The time course of stiffness change
following therapy is as yet unknown.Conclusion
The
results indicate mechanical properties of tumor tissue and surrounding liver
parenchyma change significantly early after RE therapy. The time course of
stiffness change following therapy will be studied in a future larger study, including
data on response to therapy at 6 months. Acknowledgements
This research was supported by NCI grant U01
CA172320.References
1. Dzyubak B, Glaser K, Yin M, et al. Automated Liver Stiffness
Measurements with Magnetic Resonance Elastography. Journal of magnetic resonance
imaging : JMRI 2013;38(2):371-379.
2. Gordic S, Ayache JB, Kennedy P, et al.
Value of tumor stiffness measured with MR elastography for assessment of
response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol
2017:1-10.